Growth-differentiation factor-15 for risk stratification in patients with acute chest pain

European Heart Journal

Volumn 29, Issue 23, 2008, Pages 2947-

  Bouzas Mosquera, Alberto ^a   Peteiro, Jesús ^a   Vázquez Rodríguez, José Manuel ^a   Álvarez García, Nemesio ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 15; TROPONIN I; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGE; AGED; ELECTROCARDIOGRAM; EMERGENCY WARD; HEART INFARCTION; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; THORAX PAIN; DEATH; DISEASE MARKER; BLOOD; FEMALE; HEART MUSCLE ISCHEMIA; MALE; MIDDLE AGED; NOTE; RISK ASSESSMENT;

AGED; BIOLOGICAL MARKERS; CHEST PAIN; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK ASSESSMENT;

EID: 57349132900     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn457     Document Type: Letter

References (7)

1. Eggers KM, Kempf T, Allhoff T, Lindahl B, Wallentin L, Wollert KC. Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J 2008;29:2327-2335.
2. Hachamovitch R, Di Carli MF. Methods and limitations of assessing new noninvasive tests: Part II: outcomes-based validation and reliability assessment of noninvasive testing. Circulation 2008;117:2793-2801.
3. Herlitz J, Karlson BW, Lindqvist J, Sjölin M. Important factors for the 10-year mortality rate in patients with acute chest pain or other symptoms consistent with acute myocardial infarction with particular emphasis on the influence of age. Am Heart J 2001;142:624-632.
4. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndromes. JAMA 2007;298:765-775.
5. Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Lindahl B, Horn-Wichmann R, Brabant G, Simoons ML, Armstrong PW, Califf RM, Drexler H, Wallentin L. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 2007;115:962-971.
6. Wollert KC, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T, Peter T, Siegbahn A, Venge P, Drexler H, Wallentin L. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 2007;116:1540-1548.
7. Kempf T, Björklund E, Olofsson S, Lindahl B, Allhoff T, Peter T, Tongers J, Wollert KC, Wallentin L. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J 2007;28:2858-2865.